SCHELLING CHRIS (President and Chief Executive) reported 1 transaction at ACER THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/20/2023ACC: 0000899243-23-020440
DirectorOfficer· President and Chief Executive
Since Feb 2019
-2.71M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.71M disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value per share
Direct
Shares
−2.71M
Price / share
—
Trade value
—
% of position
New position
11/17/2023
2.71M→0.00
Total
Net shares
−2.71M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share Direct | 11/17/2023 | D · Disposition | −2.71M | — | — | New position | 2.71M | 0.00 |
| Total | −2.71M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported